Trade name: Lincomix inj.
Active substance: lincomicină clorhidrat
Therapeutic group: Antibiotics
Pharmaceutical form: soluţie injectabilă
Presentation: flacon x 50, 100, 250 ml
Trade name: Lincomix inj.
Active substance: lincomicină clorhidrat
Therapeutic group: Antibiotics
Pharmaceutical form: soluţie injectabilă
Presentation: flacon x 50, 100, 250 ml
Target species: dogs, cats, swine
Therapeutic action: Caini si pisici: in tratamentul infectiilor cauzate de germeni Gram pozitivi sensibili la lincomicina (streptococi si stafilococi) si germeni Gram negativi anaerobi (Bacteroides spp sau Fusobacterium spp.) In tonsilite, laringite si alte infectii ale tractului respirator superior. In abcese, rani infectate, dermatite purulente, in septicemie atunci cand aceste afectiuni sunt determinate de germeni sensibili la lincomicina. Porcine: in tratamentul infectiilor cauzate de germeni Gram pozitivi sensibili la lincomicina (streptococi si stafilococi) si germeni Gram negativi anaerobi ( Serpulina (Treponema) hyodysenteriae, Bacteroides spp., Fusobacterium spp. si Mycoplasma spp.) Este recomandat in tratamentul dizenteriei suine, pneumoniei enzootice, artritelor septice, abcese ale ongloanelor produse de stafilococi, streptococi, Erysipelothrix spp. si Mycoplasma spp. sensibile la lincomicina.
Waiting period: Carne si organe: porcine - 3 zile.
Release mode: Cu prescripţie
Authorization number: 190156
Authorization status: Valida
Date of issue of the authorization: 13-06-2019
Authorization valid until: nelimitata
Manufacturer / Serial Release Company: CRIDA PHARM S.R.L., România
Licensee: CRIDA PHARM S.R.L., România
Responsible company in Romania: CRIDA PHARM S.R.L.